Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AVE.AX
HoldAvecho Biotechnology Limited · Healthcare · Australia · $64M · Avg Vol: $78K/d
44
StockRankGet insider-trade alerts
Q
34
V
23
M
77
P/E (TTM)
—
ROE
-182.9%
D/E
0.0x
Dividend %
—
COMPANY DESCRIPTION
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments.
FINANCIAL SUMMARY (AUD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 1.2M | 0.5M | 1.1M | 1.2M | 1.1% | 1.2M |
| EPS (AUD) | — | -0.00 | -0.00 | -0.00 | -0.00 | — | — |
| Shares | — | 3.9B | 3.2B | 3.2B | 3.7B | -4.9% | 3.9B |
| Debt | — | 0.2M | 0.2M | 1.1M | 14.5K | -61.1% | 14.5K |
| Equity | — | 2.4M | 6.4M | 3.3M | 1.6M | -14.0% | — |
| Op CF | — | -1.7M | -3.2M | -4.0M | 1.1M | — | 1.1M |
| Inv CF | -0.2M | -53.1K | — | -15.7K | 0 | — | — |
| Fin CF | — | -78.2K | 7.2M | 0.9M | 1.2M | — | — |
Loading 1Y...
PRICE (1Y)+9.5%
SMA 50SMA 200
Close
$0.0165
RSI (14)
52.9
52W High
$0.0193
From 52W High
0.9%
SCORE BREAKDOWN
Quality
34
ROIC
-61.8%12.6
ROE
-182.9%5.0
GP/Assets
12.5%31.8
Op. Margin
-198.9%14.8
FCF/Assets
-30.1%14.4
Piotroski
376.5
Int. Cover
-8.6x25.0
D/E Ratio
0.01x84.7
Current Ratio
9.95x86.2
Value
23
P/E (TTM)
—N/A
EV/EBITDA
-19.0x25.0
P/FCF
—N/A
P/B
—N/A
P/S
68.7x8.8
Div Yield
—N/A
Momentum
77
52W High %
85%74.1
RS 6M
132%98.2
SMA 50/200
1.63x99.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$64M
P/E (Forward)
—
Gross Margin
71.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AVE.AX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AVE.AX | Avecho Biotechnology Limited(you) | $64M | 44 | Hold |
| ATHE | Alterity Therapeutics Limited | $83M | 54 | Hold |
| ATX.AX | Amplia Therapeutics Limited | $53M | 30 | Sell |
| LTP.AX | LTR Pharma Limited | $61M | 24 | Sell |
| KZIA | Kazia Therapeutics Limited | $151M | 36 | Hold |
| PTX.AX | Prescient Therapeutics Limited | $50M | 22 | Sell |
| ILA.AX | Island Pharmaceuticals Limited | $93M | 19 | Strong Sell |
| SPL.AX | Starpharma Holdings Limited | $244M | 50 | Hold |
| ALA.AX | Arovella Therapeutics Limited | $53M | 14 | Strong Sell |
| IMMP | Immutep Limited | $57M | 8 | Strong Sell |
Peer medians: ROE -23.0% · P/E 35.3x · Gross margin 60.5%